Tag: Market trends

In 2024, Merck's cancer immunotherapy Keytruda solidified its position as the world's best-selling medication, generating global sales of nearly $29.5 billion. This monumental figure offers a clear answer to the question of what is the highest selling drug in the market, illustrating a significant shift in pharmaceutical leadership driven by advancements in oncology and explosive growth in metabolic therapies.

The global market for pilocarpine hydrochloride, the primary form of the drug, was valued at over $450 million in 2024 and is projected to grow significantly by 2033. Understanding what is the price of pilocarpine raw material requires a look beyond simple retail costs, as bulk pricing for Active Pharmaceutical Ingredients (API) is influenced by complex market dynamics.